RevMedica Inc

WHAT'S NEXT IN SURGICAL STAPLING

For decades, surgical stapling innovation has focused on advancing the device. RevMedica is focused on bringing real-time, objective insight to every stapling decision.

RevMedica is delivering real-time, objective data before, during, and after each deployment to empower surgeons with the insight to optimize clinical decision-making.

Empowering Through Insight

RevMedica's technology empowers surgeon expertise with real-time insight, bringing greater clarity and confidence to critical stapling decisions.

More Insight

Delivering real-time, objective, actionable data at the moment it matters.

More Insight

Delivering real-time, objective, actionable data at the moment it matters.

More Clarity

Transforming insight into meaningful understanding for more informed decisions.

More Clarity

Transforming insight into meaningful understanding for more informed decisions.

More Confidence

Empowering surgeon expertise with greater certainty before, during, and after stapling.

More Confidence

Empowering surgeon expertise with greater certainty before, during, and after stapling.

A New Approach
to Surgical
Stapling

For decades, surgical innovation has focused on mechanics, instrumentation, and procedural advancement.

We believe the future will be driven by something more important: Understanding.

The ability to transform information into meaningful insight.

To provide greater clarity during critical moments.

To empower more informed stapling decisions.

Real-time insight will empower surgical decision-making at the moment it matters most.

Delivering objective data through a real-time, easy-to-understand graphical interface creates new opportunities to advance consistency, confidence, and outcomes.

The Future
of Surgical Stapling
Is Insight-Driven

RevMedica is Bringing Insight to Every Deployment

Information alone doesn't improve decisions. Understanding does.

Greater understanding empowers greater confidence.

And greater confidence supports excellent outcomes.

Tissue assessment icon

Before

Tissue Assessment

RevMedica senses tissue characteristics — thickness and compression — giving surgeons real-time, objective data and guidance for cartridge selection.

Real-time feedback icon

During

Real-Time Feedback

As the stapler deploys, the platform monitors kinematics in real time, so abnormal conditions or obstructions can be recognized and avoided.

Staple line insight icon

After

Staple Line Insight

Staple line performance is evaluated against real-time feedback — giving surgeons the opportunity to address a potential complication before the patient leaves the OR.

Advancing the Future of Intelligent Surgical Stapling
with FDA
STeP Designation

RevMedica received an FDA Safer Technologies Program (STeP) designation.

Unlike conventional stapling systems, RevMedica is engineering stapling technology that will continuously evaluate tissue characteristics to provide actionable information that supports intraoperative decision-making.

This stapling technology is designed to objectively measure tissue characteristics before staple formation, helping surgeons make more informed decisions during one of the most critical steps of the procedure.

By providing objective information throughout tissue compression, our stapling technology is intended to reduce uncertainty, improve procedural consistency, and support more informed surgical decision-making.

FDA Safer Technologies Program (STeP) designation facilitates device development and review but does not constitute FDA clearance or approval.

This is What Drives Everything We Do.
Meet the Team That's Building Tomorrow.

Learn More About Our Technology

Connect with our team to learn more about our data-driven solution to surgical stapling.

Thomas Wenchell

Chief Executive Officer and Co-Founder
Tom co-founded RevMedica in 2017, with the vision to revolutionize surgical procedures.
 
With over 30 years of experience in the medical device industry and a wealth of expertise in engineering and product development, Tom has established himself as a global leader in the field. He possesses over 100 issued patents, a testament to his innovative contributions to the industry. 
Tom's accomplishments speak to his ability to navigate complex challenges and drive innovation in the medical device industry. At RevMedica, Tom leads the development of a novel, handheld robotic solution intended to optimize clinical decision-making and improve patient safety with a cost-effective and environmentally friendly surgical system.
 
Under his leadership, RevMedica has amassed a robust patent portfolio, assembled a team of key advisers, and successfully demonstrated the feasibility of RevMedica’s core design. Tom’s visionary leadership extends beyond product development.
 
He has played a pivotal role in shaping RevMedica's strategic direction, building a talented team, and securing funding to support the company's growth. His hands-on approach to every aspect of the business underscores his dedication to ensuring the success of RevMedica.